Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Arthritis Care & Research|July 26, 2018
Time of Disease-Modifying Antirheumatic Drug Start in Juvenile Idiopathic Arthritis and the Likelihood of a Drug-Free Remission in Young AdulthoodKirsten Minden, Gerd Horneff, Martina Niewerth, et al.
Arthritis and Rheumatism|October 29, 2005
Infections in patients with rheumatoid arthritis treated with biologic agentsJoachim Listing, Anja Strangfeld, Sonja Kary, et al.
Arthritis Research & Therapy|May 19, 2005
Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximabXenofon Baraliakos, Joachim Listing, Jan Brandt, et al.
Arthritis Research & Therapy|December 15, 2018
Vitamin D deficiency is associated with higher disease activity and the risk for uveitis in juvenile idiopathic arthritis - data from a German inception cohortClaudia Sengler, Julian Zink, Jens Klotsche, et al.
Annals of the Rheumatic Diseases|June 17, 2016
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registersLouise K Mercer, Johan Askling, Pauline Raaschou, et al.
Seminars in Arthritis and Rheumatism|August 3, 2010
A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registriesJeffrey R Curtis, Archana Jain, Johan Askling, et al.
Pharmacoepidemiology and Drug Safety|August 14, 2024
Rhekiss-The German Register for Child Wish and Pregnancies in Inflammatory Rheumatic DiseasesAnja Strangfeld, Yvette Meissner, Anja Weiß, et al.
Annals of the Rheumatic Diseases|October 15, 2020
EULAR recommendations for a core data set for pregnancy registries in rheumatologyYvette Meissner, Rebecca Fischer-Betz, Laura Andreoli, et al.
RMD Open|February 5, 2019
EULAR 'points to consider' for the conduction of workforce requirement studies in rheumatologyChristian Dejaco, Polina Putrik, Julia Unger, et al.
Annals of the Rheumatic Diseases|February 19, 2016
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactationCarina Götestam Skorpen, Maria Hoeltzenbein, Angela Tincani, et al.
Pageof 11